Skip to main content

Table 2 Genes annotated for developmental processes, reproduction and/or embryo development between female, male and hermaphrodite flower buds (size 7 to 12 mm)

From: Differential gene expression among three sex types reveals a MALE STERILITY 1 (CpMS1) for sex differentiation in papaya

Gene IDDescriptionLogCPMMale
vs. Female
Male vs.
Hermaphrodite
Hermaphrodite
vs. Female
FC*FDR*FC*FDR*FC*FDR*
evm.model.supercontig_2.119PHD Finger MALE STERILITY 15.873350.227.72E-031.071.00E+ 003118.568.87E-03
evm.model.supercontig_157.32Glucan endo-1,3-beta-glucosidase-like5.2075.591.38E-022.317.94E-0132.783.33E-02
evm.model.supercontig_72.35Egg cell secreted protein-like−0.2556.372.66E-023.136.71E-0118.041.04E-01
evm.model.supercontig_3.299Cellulose synthase–like protein D1−0.3323.884.03E-021.331.00E+ 0017.986.28E-02
evm.model.supercontig_182.26Cytokinin dehydrogenase 60.9517.908.92E-038.149.47E-022.207.73E-01
evm.model.supercontig_14.52Actin cross-linking (DUF569)0.9413.071.28E-026.391.35E-012.057.61E-01
evm.model.supercontig_50.85Glycerol-3-phosphate acyltransferase 15.7010.391.30E-02−1.201.00E+ 0012.491.04E-02
evm.model.supercontig_1525.1Abscisic acid 8-hydroxylase 15.229.792.90E-05−1.671.26E-0116.311.38E-05
evm.model.supercontig_85.48Probable kinase1.808.781.07E-021.211.00E+ 007.242.39E-02
evm.model.supercontig_11.32Calmodulin-binding receptor-like cytoplasmic kinase 24.724.032.88E-051.229.77E-013.318.43E-05
evm.model.supercontig_6.104Steroid 22-alpha-hydroxylase /cytochrome P450 90B1-like3.973.315.19E-031.191.00E+ 002.782.40E-02
evm.model.supercontig_27.166G-type lectin S-receptor-like serine threonine-kinase RKS14.483.222.73E-041.881.41E-011.711.98E-01
evm.model.supercontig_89.64Homeobox-leucine zipper HAT4-like5.043.201.94E-051.671.14E-011.921.64E-02
evm.model.supercontig_75.17E3 ubiquitin-protein ligase XBAT32/334.142.974.10E-03−1.359.01E-014.022.85E-04
evm.model.supercontig_26.316Floral homeotic protein PISTILLATA6.992.801.39E-041.305.57E-012.161.03E-03
evm.model.supercontig_26.81Protein GIGANTEA7.412.513.21E-031.482.67E-011.706.18E-02
evm.model.supercontig_26.82GIGANTEA-like9.072.501.54E-041.403.04E-011.787.36E-03
evm.model.supercontig_23.39UDP-sugar transporter/Solute carrier family 35 (SLC35D)4.452.389.96E-031.604.23E-011.494.23E-01
evm.model.supercontig_44.60Transcription factor MYB4-like1.682.225.37E-018.952.66E-02−4.031.88E-01
evm. TU.contig_29408.2Metal-nicotianamine transporter YSL36.632.111.14E-041.471.46E-011.431.33E-01
evm.model.supercontig_87.13PHD Finger MALE MEIOCYTE DEATH 10.111.988.37E-01−8.141.53E-0116.082.38E-02
evm.model.supercontig_1.61Serine threonine-kinase STY464.671.963.69E-021.161.00E+ 001.681.54E-01
evm.model.supercontig_20.162Expansin-like A26.351.381.94E-01−1.471.35E-012.037.58E-04
evm.model.supercontig_13.86Tetraspanin-11 related2.43−1.011.00E+ 00−7.967.60E-037.874.14E-03
evm. TU.contig_30608.1CRABS CLAW/ HMG-box domain (HMG box 2)7.20−1.509.34E-021.501.80E-01−2.252.14E-03
evm.model.supercontig_97.108Epidermis-specific secreted glyco EP1-like/ COMITIN4.66−1.582.26E-011.712.10E-01−2.718.29E-04
evm.model.supercontig_4.62Callose synthase 104.99−1.593.28E-01−3.621.35E-022.285.43E-02
evm.model.supercontig_27.172G-type lectin S-receptor-like serine threonine- kinase B1204.56−1.761.26E-011.211.00E+ 00−2.132.44E-02
evm.model.supercontig_16.181Condensin-2 complex subunit D3 (NCAPD3)4.54−1.888.63E-02−2.972.11E-031.582.84E-01
evm.model.supercontig_115.9Transcription factor HY55.54−1.921.10E-031.051.00E+ 00−2.014.61E-04
evm.model.supercontig_75.60Protein kinase PINOID 25.61−2.091.61E-041.257.16E-01−2.611.97E-05
evm.model.supercontig_12.194Scarecrow-like transcription factor PAT17.00−2.131.63E-04−2.105.92E-04−1.019.96E-01
evm.model.supercontig_132.29E3 ubiquitin- ligase COP1-like/ Protein suppressor of PHYA-105 14.30−2.184.00E-02−1.061.00E+ 00−2.066.58E-02
evm.model.supercontig_621.3Major facilitator protein/ Spinster homolog 34.27−2.312.98E-02−1.575.77E-01−1.475.17E-01
evm.model.supercontig_84.92Histone H3 isoform 16.36−2.411.58E-04−1.081.00E+ 00−2.243.17E-04
evm.model.supercontig_233.1AP2-like ethylene-responsive transcription factor AIL55.82−2.544.40E-05−2.282.83E-04−1.118.64E-01
evm.model.supercontig_84.93Histone H3 isoform 25.65−2.858.95E-051.071.00E+ 00−3.047.75E-05
evm.model.supercontig_97.109COMITIN2.68−2.922.89E-01−6.832.47E-022.343.89E-01
evm.model.supercontig_200.13Cyclin-D3–14.91−3.191.38E-04−2.759.81E-04−1.168.45E-01
evm.model.supercontig_3.468Kinesin-like protein NACK14.73−3.351.45E-04−2.251.57E-02−1.493.23E-01
evm.model.supercontig_53.153Shugoshin-1-like/ Shugosin C terminus3.12−3.633.33E-02−3.091.28E-01−1.179.58E-01
evm.model.supercontig_81.9Kinesin family member C1 (KIFC1)5.45−3.888.46E-05−1.832.73E-02−2.123.39E-03
evm.model.supercontig_125.26DNA topoisomerase 2 (TOP2)5.65−3.931.03E-04−1.803.67E-02−2.183.47E-03
evm.model.supercontig_21.170WUSCHEL-related homeobox 44.45−4.381.31E-04−2.323.59E-02−1.899.26E-02
evm.model.supercontig_151.451,4-beta-D-xylan synthase5.73−4.906.66E-05−2.181.27E-02−2.254.04E-03
evm.model.supercontig_160.4Receptor kinase HAIKU29.55−5.042.34E-04−2.551.29E-02−1.983.24E-02
evm.model.supercontig_129.70AP2-like ethylene-responsive transcription factor ANT4.92− 5.603.90E-04−2.226.02E-02−2.521.30E-02
evm.model.supercontig_18.81Transcription factor UPBEAT12.86−5.657.56E-03−4.534.53E-02−1.259.29E-01
evm.model.supercontig_160.33AP2-like ethylene-responsive transcription factor ANT5.37−5.941.66E-05−1.423.44E-01−4.196.01E-05
evm.model.supercontig_52.111VAN3-binding/Auxin canalisation (Auxin canalis)5.61−6.014.68E-06−1.964.19E-03−3.066.53E-05
evm.model.supercontig_25.116AP2-like ethylene-responsive transcription factor AIL12.96−6.821.68E-031.679.08E-01−11.431.37E-04
evm.model.supercontig_26.241Cytochrome P450 83B1 (CYP83B1)4.92−8.814.39E-04−8.421.36E-03−1.059.87E-01
evm.model.supercontig_444.5Beta-glucosidase 27-like1.15−20.469.46E-03−6.732.02E-01−3.043.87E-01
evm.model.supercontig_1.155Cytochrome P450 85A-like/ Brassinosteroid-6-oxidase 2
(CYP85A2, BR6OX2)
−0.77−104.771.73E-02−8.576.54E-01−12.227.15E-02
  1. aDifferentially expressed genes parameters: Fold-Change (FC) > 2 or < −2 and a False Discovery Rate (FDR) < 0.05